Importer of Controlled Substances; Notice of Application, 9606 [E6-2645]

Download as PDF 9606 Federal Register / Vol. 71, No. 37 / Friday, February 24, 2006 / Notices APPA that were considered by the United States in formulating the proposed Final Judgment. Dated: February 6, 2006. Respectfully submitted, Peter J. Mucchetti, Mitchell H. Glende, Attorneys for the United States, United States Department of Justice, 1401 H Street, NW., Suite 4000, Washington, DC 20530. Telephone: (202) 353–4211. Facsimile: (202) 307–5802. Charles T. Miller, Acting United States Attorney. Kelly R. Curry, Assistant United States Attorney. [FR Doc. 06–1696 Filed 2–23–06; 8:45am] BILLING CODE 4410–11–M DEPARTMENT OF JUSTICE Drug Enforcement Administration wwhite on PROD1PC65 with NOTICES Importer of Controlled Substances; Notice of Application Pursuant to 21 U.S.C. 958(i), the Attorney General shall, prior to issuing a registration under this Section to a bulk manufacturer of a controlled substance in Schedules I or II and prior to issuing a regulation under 21 U.S.C. 952(a)(2)(B) authorizing the importation of such a substance, provide manufacturers holding registrations for the bulk manufacture of the substance an opportunity for a hearing. Therefore, in accordance with 21 CFR 1301.34(a), this is notice that on September 2, 2005, JFC Technologies, LLC., 100 West Main Street, P.O. Box 669, Bound Brook, New Jersey 08805, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of Meperidine intermediate-B (9233), a basic class of controlled substance listed in Schedule II. The company plans to import the basic class of controlled substance for the production of other controlled substances for distribution to its customers. Any manufacturer who is presently, or is applying to be, registered with DEA to manufacture such basic classes of controlled substances may file comments or objections to the issuance of the proposed registration and may, at the same time, file a written request for a hearing on such application pursuant to 21 CFR 1301.43 and in such form as prescribed by 21 CFR 1316.47. Any such written comments or objections being sent via regular mail may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug VerDate Aug<31>2005 18:03 Feb 23, 2006 Jkt 208001 Enforcement Administration, Washington, DC 20537, Attention: DEA Federal Register Representative, Liaison and Policy Section (ODL); or any being sent via express mail should be sent to DEA Headquarters, Attention: DEA Federal Register Representative/ODL, 2401 Jefferson-Davis Highway, Alexandria, Virginia 22301; and must be filed no later than March 27, 2006. This procedure is to be conducted simultaneously with and independent of the procedures described in 21 CFR 1301.34(b), (c), (d), (e) and (f). As noted in a previous notice published in the Federal Register on September 23, 1975, (40 FR 43745–46), all applicants for registration to import a basic class of any controlled substance listed in Schedules I or II are, and will continue to be required to demonstrate to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, that the requirements for such registration pursuant to 21 U.S.C. 958(a), 21 U.S.C. 823(a), and 21 CFR 1301.34(b), (c), (d), (e) and (f) are satisfied. Dated: February 16, 2006. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E6–2645 Filed 2–23–06; 8:45 am] BILLING CODE 4410–09–P February 15, 2006. Michael H. Allen, Acting Assistant Attorney General for Administration. JUSTICE/BOP–011 SYSTEM NAME: * Telephone Activity Record System. * * * * RETENTION AND DISPOSAL: With the exception of audiotapes and digital recordings, automated records in this system are maintained on magnetic medium ordinarily for six years from the date created, at which time they will be overwritten with new data. Paper documents are maintained for a period of 30 years from expiration of sentence of the inmate, at which time they are destroyed by shredding. Audiotapes and digital recordings are maintained ordinarily for six months from the date created, at which time they are overwritten with new data. * * * * * [FR Doc. E6–2678 Filed 2–23–06; 8:45 am] BILLING CODE 4410–05–P DEPARTMENT OF LABOR Office of the Secretary Submission for OMB Review: Comment Request February 16, 2006. DEPARTMENT OF JUSTICE Bureau of Prisons [AAG/A Order No. 001–2006] Privacy Act of 1974; Modification to System of Records Pursuant to the Privacy Act of 1974 (5 U.S.C. 552a), notice is given that the Federal Bureau of Prisons (BOP) is making a minor modification to its system of records notice entitled ‘‘Telephone Activity Record System, JUSTICE/BOP–011’’. This system notice was last published on April 8, 2002 (67 FR 16762). The BOP is revising the system’s provision for ‘‘Retention and Disposal’’ to include retention and disposal of digital recordings. This minor change does not require an opportunity for public comment or notification of Congress and the Office of Management and Budget. The modification will be effective on the date of publication in the Federal Register. The language of the minor modification is provided below. PO 00000 Frm 00094 Fmt 4703 Sfmt 4703 The Department of Labor (DOL) has submitted the following public information collection requests (ICR) to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995 (Pub. L. 104–13, 44 U.S.C. chapter 35). A copy of this ICR, with applicable supporting documentation, may be obtained by contacting Darrin King on 202–693– 4129 (this is not a toll-free number) or e-mail: king.darrin@dol.gov. Comments should be sent to Office of Information and Regulatory Affairs, Attn: OMB Desk Officer for the Occupational Safety and Health Administration (OSHA), Office of Management and Budget, Room 10235, Washington, DC 20503, 202–395–7316 (this is not a toll-free number), within 30 days from the date of this publication in the Federal Register. The OMB is particularly interested in comments which: • Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; E:\FR\FM\24FEN1.SGM 24FEN1

Agencies

[Federal Register Volume 71, Number 37 (Friday, February 24, 2006)]
[Notices]
[Page 9606]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-2645]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Application

    Pursuant to 21 U.S.C. 958(i), the Attorney General shall, prior to 
issuing a registration under this Section to a bulk manufacturer of a 
controlled substance in Schedules I or II and prior to issuing a 
regulation under 21 U.S.C. 952(a)(2)(B) authorizing the importation of 
such a substance, provide manufacturers holding registrations for the 
bulk manufacture of the substance an opportunity for a hearing.
    Therefore, in accordance with 21 CFR 1301.34(a), this is notice 
that on September 2, 2005, JFC Technologies, LLC., 100 West Main 
Street, P.O. Box 669, Bound Brook, New Jersey 08805, made application 
by renewal to the Drug Enforcement Administration (DEA) to be 
registered as an importer of Meperidine intermediate-B (9233), a basic 
class of controlled substance listed in Schedule II.
    The company plans to import the basic class of controlled substance 
for the production of other controlled substances for distribution to 
its customers.
    Any manufacturer who is presently, or is applying to be, registered 
with DEA to manufacture such basic classes of controlled substances may 
file comments or objections to the issuance of the proposed 
registration and may, at the same time, file a written request for a 
hearing on such application pursuant to 21 CFR 1301.43 and in such form 
as prescribed by 21 CFR 1316.47.
    Any such written comments or objections being sent via regular mail 
may be addressed, in quintuplicate, to the Deputy Assistant 
Administrator, Office of Diversion Control, Drug Enforcement 
Administration, Washington, DC 20537, Attention: DEA Federal Register 
Representative, Liaison and Policy Section (ODL); or any being sent via 
express mail should be sent to DEA Headquarters, Attention: DEA Federal 
Register Representative/ODL, 2401 Jefferson-Davis Highway, Alexandria, 
Virginia 22301; and must be filed no later than March 27, 2006.
    This procedure is to be conducted simultaneously with and 
independent of the procedures described in 21 CFR 1301.34(b), (c), (d), 
(e) and (f). As noted in a previous notice published in the Federal 
Register on September 23, 1975, (40 FR 43745-46), all applicants for 
registration to import a basic class of any controlled substance listed 
in Schedules I or II are, and will continue to be required to 
demonstrate to the Deputy Assistant Administrator, Office of Diversion 
Control, Drug Enforcement Administration, that the requirements for 
such registration pursuant to 21 U.S.C. 958(a), 21 U.S.C. 823(a), and 
21 CFR 1301.34(b), (c), (d), (e) and (f) are satisfied.

    Dated: February 16, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
 [FR Doc. E6-2645 Filed 2-23-06; 8:45 am]
BILLING CODE 4410-09-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.